Partners Group targets newer vintages and complex portfolios
Co-chief executive David Layton says he is 'pleased' that most pre-crisis dealflow has worked its way through the system.
Germany’s Capiton eyes single-asset pharma deal – exclusive
Park Hill is understood to be running the process which involves omega-3 producer KD Pharma Bexbach.
Secondaries market set for another record year – NYPPEX
At least $36bn worth of fund stakes changed hands in the first half of the year with GP-led deals accounting for 34% of the total, according to the intermediary.
How LGT applies ESG filters to secondaries deals
Partner Martha Heitmann discusses ESG-driven secondaries sales and what to do if a portfolio sets off alarms.
HarbourVest boosts EM exposure through Amadeus deal
The deal involves stakes in 10 emerging-market assets from MTN Group, Africa's largest telecoms company.
Blackstone Tac Opps Fund runs single-asset restructuring – exclusive
The deal involves Phoenix Tower International, which is held in the firm's $7bn 2012-vintage vehicle.
Unigestion a net seller over past 12 months
The investment manager has sold more than €150m of tail-end stakes from its primary vehicles and evergreen mandates.
British Columbia shops private equity portfolio
The portfolio is understood to be worth between $250m and $500m, according to sister publication Buyouts.
AlpInvest to back Warburg single-asset deal – exclusive
The process on the 2011-vintage $11.2bn Fund XI will give the private equity giant liquidity while allowing it to continue managing a prize asset.
GP stakes: Coller, Glendower among prime secondaries targets
Newbury Partners, Pomona and Montana are also among the most suitable candidates for a GP stake investment, according to a report by PitchBook.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please email: subscriptions@peimedia.com.